{"transactions":[{"id":949869,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:08:56.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":539265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5201069,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":539265},"source":{"system":"sec-edgar","filing":"0001834418-26-000002","document":"wk-form4_1767632934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441826000002/wk-form4_1767632934.xml","form_type":"4"}},{"id":1313308,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:40:45.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":832033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":4661804,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":832033},"source":{"system":"sec-edgar","filing":"0001628280-25-000235","document":"wk-form4_1735936840.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000235/wk-form4_1735936840.xml","form_type":"4"}},{"id":1470276,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2024-06-24T22:38:32.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3829771,"derivative":{"exercise_price":0.188,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001628280-24-029675","document":"wk-form4_1719268705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024029675/wk-form4_1719268705.xml","form_type":"4"}},{"id":1470275,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2024-06-24T22:38:32.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":83334,"price":0.188,"value":15666.792,"ownership":{"direct":true},"balance_after":2123456,"source":{"system":"sec-edgar","filing":"0001628280-24-029675","document":"wk-form4_1719268705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024029675/wk-form4_1719268705.xml","form_type":"4"}},{"id":1678895,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:23:50.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":770416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3913105,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":770416},"source":{"system":"sec-edgar","filing":"0001703057-24-000008","document":"wk-form4_1705447421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000008/wk-form4_1705447421.xml","form_type":"4"}},{"id":1780767,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2023-09-14T20:38:44.000Z","date":"2023-09-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":5.19,"value":103800.0,"ownership":{"direct":true},"balance_after":2040122,"source":{"system":"sec-edgar","filing":"0001703057-23-000030","document":"wk-form4_1694723915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000030/wk-form4_1694723915.xml","form_type":"4"}},{"id":1899156,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2023-05-09T19:02:28.000Z","date":"2023-05-05","kind":"exercise","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3142689,"derivative":{"exercise_price":0.19,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-23-028214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123028214/doc4.xml","form_type":"4"}},{"id":1899155,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2023-05-09T19:02:28.000Z","date":"2023-05-05","kind":"exercise","planned":false,"acquired":true,"shares":250000,"price":0.19,"value":47500.0,"ownership":{"direct":true},"balance_after":2020122,"source":{"system":"sec-edgar","filing":"0001209191-23-028214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123028214/doc4.xml","form_type":"4"}},{"id":2095496,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:28:50.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":462535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first\ntranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3392689,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":462535},"source":{"system":"sec-edgar","filing":"0001209191-22-059573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059573/doc4.xml","form_type":"4"}},{"id":2267290,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2022-05-17T19:07:35.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":200000,"price":6.3389,"value":1267780.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.22 to $6.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":1770122,"source":{"system":"sec-edgar","filing":"0001209191-22-029542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122029542/doc4.xml","form_type":"4"}},{"id":2364247,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2022-03-02T00:49:14.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":230789,"price":8.66,"value":1998632.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased at prices ranging from $8.48 to $8.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information\nregarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1570122,"source":{"system":"sec-edgar","filing":"0001209191-22-014395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122014395/doc4.xml","form_type":"4"}},{"id":2412818,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2022-02-04T00:00:41.000Z","date":"2021-12-08","kind":"gift","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents a charitable donation of 250,000 common shares the reporting person donated on December 8, 2021."}],"balance_after":1339333,"source":{"system":"sec-edgar","filing":"0001209191-22-006972","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122006972/doc5.xml","form_type":"5"}},{"id":2412817,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2022-02-04T00:00:41.000Z","date":"2021-11-30","kind":"gift","acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a charitable donation of 83,333 common shares the reporting person donated on November 30, 2021."}],"balance_after":1339333,"source":{"system":"sec-edgar","filing":"0001209191-22-006972","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122006972/doc5.xml","form_type":"5"}},{"id":2478523,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share Option","published_at":"2021-12-09T23:01:56.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":406020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":2930154,"derivative":{"exercise_price":14.55,"expiration_date":"2031-12-07","underlying":"Common Shares","underlying_shares":406020},"source":{"system":"sec-edgar","filing":"0001209191-21-068851","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121068851/doc4.xml","form_type":"4"}},{"id":2478518,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-12-09T22:49:52.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":2524134,"derivative":{"exercise_price":0.19,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-21-068844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121068844/doc4.xml","form_type":"4"}},{"id":2478517,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2021-12-09T22:49:52.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":250000,"price":0.19,"value":47500.0,"ownership":{"direct":true},"balance_after":1589333,"source":{"system":"sec-edgar","filing":"0001209191-21-068844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121068844/doc4.xml","form_type":"4"}},{"id":2484850,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-12-03T22:47:51.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":2774134,"derivative":{"exercise_price":0.19,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001209191-21-067941","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121067941/doc4a.xml","form_type":"4/A","original_submission_date":"2021-12-02"}},{"id":2484849,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2021-12-03T22:47:51.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":83333,"price":0.19,"value":15833.27,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The original price was listed as $14.96 which is an administrative error. The correct price is $0.19."}],"balance_after":1422666,"source":{"system":"sec-edgar","filing":"0001209191-21-067941","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121067941/doc4a.xml","form_type":"4/A","original_submission_date":"2021-12-02"}},{"id":2488060,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-12-02T19:16:59.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":2774134,"derivative":{"exercise_price":0.19,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001209191-21-067491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121067491/doc4.xml","form_type":"4"}},{"id":2488059,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2021-12-02T19:16:59.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":83333,"price":14.96,"value":1246661.68,"ownership":{"direct":true},"balance_after":1422666,"source":{"system":"sec-edgar","filing":"0001209191-21-067491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121067491/doc4.xml","form_type":"4"}},{"id":2665450,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-06-17T00:00:11.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":333333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Per share exercise price has been converted from CAD to USD based on the grant date exchange ratio of CAD $1.333:USD $1.00 for March 23, 2017 as set forth on Bloomberg."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on November 8, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Expiration date corrected from the date listed on the Form 3 filed on December 11, 2020."}],"balance_after":666667,"derivative":{"exercise_price":0.19,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0000899243-21-024295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321024295/doc4.xml","form_type":"4"}},{"id":2665449,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2021-06-17T00:00:11.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":333333,"price":0.19,"value":63333.27,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Per share exercise price has been converted from CAD to USD based on the grant date exchange ratio of CAD $1.333:USD $1.00 for March 23, 2017 as set forth on Bloomberg."}],"balance_after":1339333,"source":{"system":"sec-edgar","filing":"0000899243-21-024295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321024295/doc4.xml","form_type":"4"}},{"id":2673266,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2021-06-10T21:01:34.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":1000000,"price":25.5,"value":25500000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of the shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), to the extent of 23,000 shares, with the purchase by the Reporting Person of 6,000 shares at a price of $20 per share on December 15, 2020, and the purchase by the Reporting Person's spouse of 17,000 shares at a price of $20 per share on December 15, 2020, as reported previously on the Reporting Person's Form 4 filed on December 17, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein."}],"balance_after":273630,"source":{"system":"sec-edgar","filing":"0000899243-21-022990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022990/doc4.xml","form_type":"4"}},{"id":2939096,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-18T01:30:14.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":190800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to such option vest and become exercisable on December 31, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":190800,"derivative":{"exercise_price":20,"expiration_date":"2030-12-10","underlying":"Common Shares","underlying_shares":190800},"source":{"system":"sec-edgar","filing":"0000899243-20-034342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034342/doc4.xml","form_type":"4"}},{"id":2939095,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-18T01:30:14.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares (\"Stock Split\"). This amount has been adjusted to give effect to the Stock Split."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price reported above was converted from the Canadian exercise price of CAD $3.08 using an exchange rate of CAD $1.27840 = US $1.00."},{"field":"kind","element":"transactionCoding","label":"F7","text":"This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are held by Pacific Swell Capital Corp (\"Pacific Swell\"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option vest and become exercisable on October 29, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares (\"Stock Split\"). This amount has been adjusted to give effect to the Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares (\"Stock Split\"). This amount has been adjusted to give effect to the Stock Split."}],"balance_after":2000000,"derivative":{"exercise_price":2.41,"expiration_date":"2030-10-29","underlying":"Common Shares","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000899243-20-034342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034342/doc4.xml","form_type":"4"}},{"id":2939094,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2020-12-18T01:30:14.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":17000,"price":20,"value":340000.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":61580,"source":{"system":"sec-edgar","filing":"0000899243-20-034342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034342/doc4.xml","form_type":"4"}},{"id":2939093,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2020-12-18T01:30:14.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":6000,"price":20,"value":120000.0,"ownership":{"direct":true},"balance_after":1006000,"source":{"system":"sec-edgar","filing":"0000899243-20-034342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924320034342/doc4.xml","form_type":"4"}}]}